Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-180860
Filing Date
2025-08-14
Accepted
2025-08-14 16:45:18
Documents
79
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q iobt-20250630.htm   iXBRL 10-Q 2770610
2 EX-31.1 iobt-ex31_1.htm EX-31.1 17959
3 EX-31.2 iobt-ex31_2.htm EX-31.2 17815
4 EX-32.1 iobt-ex32_1.htm EX-32.1 10286
5 EX-32.2 iobt-ex32_2.htm EX-32.2 10145
6 GRAPHIC img135872921_0.jpg GRAPHIC 85197
7 GRAPHIC img135872921_1.jpg GRAPHIC 279215
  Complete submission text file 0001193125-25-180860.txt   10731687

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iobt-20250630.xsd EX-101.SCH 1196079
82 EXTRACTED XBRL INSTANCE DOCUMENT iobt-20250630_htm.xml XML 1655078
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41008 | Film No.: 251220347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)